UroGen Pharma Ltd (URGN) — Capital Reinvestment Ratio
UroGen Pharma Ltd (URGN) has a Capital Reinvestment Ratio of 0.01x as of September 2017, meaning it reinvests 0% of its operating cash flow ($2.60 Million) in capital expenditures ($20.00K). Check URGN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
UroGen Pharma Ltd Capital Reinvestment Ratio (2016–2016)
This chart tracks UroGen Pharma Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see URGN cash flow metrics.
Annual Capital Reinvestment Ratio for UroGen Pharma Ltd (2016–2016)
Year-by-year Capital Reinvestment Ratio for UroGen Pharma Ltd from 2016 to 2016. See UroGen Pharma Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.17x | $4.19 Million | $695.00K | — |